About this course
This course gives you a fundamental understanding of how our immune system functions. You are introduced to the cells and factors which mediate the various types of innate and adaptive immune responses. The course also covers clinically relevant topics such as allergic reactions, tumor immunology, and immunology of infections. Examples of therapeutic and prophylactic interventions arising from the latest advances in immunology such as CAR T-cells for cancer treatment and vaccine candidates for SARS-CoV-2, are used to illustrate these concepts.
Syllabus
Faculty
Lubna Khatoon
FacultyPhD (Biochemistry/ Molecular Biology, Quaid-i-Azam University Pakistan and University of California Irvine, USA, 2010). Assistant Professor, Agriculture University Faisalabad Pakistan, 2008-2012. Post Doc. (University of Sydney, Australia 2012), Research Assistant (Copenhagen University Denmark, 2013). Quality control Coordinator (Coop Denmark, 2015-2021), Lecturer (European School Copenhagen, since 2022). With DIS since 2024.
Jeanette Erbo Wern
Faculty; Senior Research ManagerPostdoc (Inst. of International Health, Immunology and Microbiology, University of Copenhagen, Denmark, 2006-2009). Ph.D. (Immunology, Inst. Of International Health, Immunology and Microbiology, University of Copenhagen, 2005). M.Sc. (Inst. Of International Health, Immunology and Microbiology, University of Copenhagen, 2001). Senior Scientist, Immune Targeting Group, Bioneer, Copenhagen, Denmark, 2010-2013. Senior Scientist, Dept. of Infectious Disease Immunology, Statens Serum Institute, Copenhagen, Denmark, 2013-2016. With DIS since 2016.
Samra Sardar
FacultyBachelor of Medicine, Bachelor of Surgery (M.B.B.S.), University of Health Sciences Pakistan, 2003-2009. M.Sc., Molecular Biology, Vrije University Brussels, 2010-2011. Ph.D., Immunology & Infectious Diseases, University of Copenhagen, 2013-2017. Research Scientist, Nordic Bioscience, 2018-2019. Global Medical Manager, Leo Pharm, 2019-2022. Global Medical Lead Grunenthal, 2022-2024. Managing Director, PharmaTech Consult, 2024-Present. With DIS since 2024.